Followers | 60 |
Posts | 8911 |
Boards Moderated | 1 |
Alias Born | 06/20/2008 |
Tuesday, April 03, 2012 2:55:09 PM
Credit Suisse High Yield Bond Fund
Eleven Madison Avenue
New York, New York 10010
DHY Announces Monthly Dividend
For Immediate Release
April 2, 2012
Contact: Investor Relations
Credit Suisse Asset Management, LLC
1-800-293-1232
New York, New York. The Board of Trustees of Credit Suisse High Yield Bond Fund (NYSE Amex: DHY), a closed-end investment company managed by Credit Suisse Asset Management, LLC, has declared a dividend of $0.0265 per share of
beneficial interest payable on April 24, 2012 to shareholders of record as of April 18, 2012. The ex-dividend date is April 16, 2012.
Credit Suisse Asset Management, LLC, would like to remind shareholders that a portion of the Fund’s fiscal year 2012 dividend may be a return of capital and that such
determination has not yet been made. The Fund’s Board of Trustees periodically assesses the level of the Fund’s monthly distributions for its continued appropriateness
in light of the Fund’s investment experience.
* * * * * * * * *
Credit Suisse Asset Management, LLC, the Fund’s investment adviser, is part of the Asset Management business of Credit Suisse Group AG, a leading global financial
services organization headquartered in Zurich.
Recent DHY News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/27/2024 06:33:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/19/2024 05:03:31 PM
- Form N-CEN - Annual Report for Registered Investment Companies • Edgar (US Regulatory) • 01/12/2024 09:18:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 03:01:34 PM
- Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). • Edgar (US Regulatory) • 01/05/2024 02:37:50 PM
- Form N-CSR - Certified Shareholder Report • Edgar (US Regulatory) • 01/05/2024 02:29:50 PM
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 12/28/2023 04:08:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 01:32:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:08:20 PM
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 09/28/2023 01:22:02 PM
- Form N-PX - Annual Report of proxy voting record of management investment companies • Edgar (US Regulatory) • 07/24/2023 04:33:25 PM
- Form N-CSRS - Certified Shareholder Report, Semi-Annual • Edgar (US Regulatory) • 06/30/2023 06:24:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM